A recent study conducted in Norway suggests that MDMA-assisted therapy may provide lasting relief for individuals suffering from major depressive disorder. The findings indicate that the clinical ...

The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.

The consensus statement affirms that lifestyle interventions—optimal nutrition, physical activity, restorative sleep, stress management, connectedness, and avoidance of risky substances—are integral ...

Findings reveal that vagus nerve stimulation leads to lasting benefits in treatment-resistant depression, improving function ...

Researchers from Hiroshima University in Japan and collaborating institutions have found that adults with asthma who ...

Johnson & Johnson’s decision to splash out $14.6 billion on its purchase of Intra-Cellular Therapies earlier this year was largely driven by the acquired company's rising antipsychotic star Caplyta ...

Rates of depression notably spiked during the pandemic. But even though life has largely returned to normal, we’re still in a mental health crisis. In 2023, the U.S. Surgeon General declared an ...